3D Echocardiography - A Useful Method for Cardiovascular Risk Assessment in End-Stage Renal Disease Patients

Area of Science:

• Nephrology
• Cardiology
• Medical Imaging

Background:

• Patients with chronic kidney disease (CKD) face high cardiovascular mortality risk.
• Hemodialysis is linked to accelerated atherosclerosis.
• Ankle-brachial index (ABI) predicts cardiovascular events but its role in CKD is unclear.

Purpose of the Study:

• To identify subclinical cardiovascular risk markers using ABI and echocardiography in end-stage renal disease (ESRD) patients.
• To compare cardiac structure and function in hemodialysis patients, kidney transplant recipients, and controls.
• To evaluate the utility of 2D and 3D echocardiography in assessing cardiac abnormalities in CKD.

Main Methods:

• Assessed ABI and echocardiographic parameters (2D and 3D) in ESRD (dialysis), post-transplant, and control groups.
• Evaluated left ventricular (LV) structure and function.
• Compared sensitivity of various echocardiographic indices for cardiac changes.

Main Results:

• Cardiac structural changes are more pronounced than functional changes in hemodialysis patients.
• 3D echocardiography is more sensitive than 2D for assessing myocardial structure and function in CKD.
• ABI is not a suitable screening tool for cardiovascular risk in ESRD patients.
• Kidney transplantation showed a trend towards favorable cardiac remodeling, particularly in function, but differences were not statistically significant.

Conclusions:

• Ankle-brachial index is inappropriate for screening cardiovascular risk in end-stage renal disease patients.
• 3D echocardiography offers superior assessment of cardiac structural and functional abnormalities in CKD.
• Kidney transplantation may improve cardiac parameters, warranting further investigation.